Correlation Between NeOnc Technologies and Insight Molecular

Can any of the company-specific risk be diversified away by investing in both NeOnc Technologies and Insight Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeOnc Technologies and Insight Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeOnc Technologies Holdings, and Insight Molecular Diagnostics, you can compare the effects of market volatilities on NeOnc Technologies and Insight Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeOnc Technologies with a short position of Insight Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeOnc Technologies and Insight Molecular.

Diversification Opportunities for NeOnc Technologies and Insight Molecular

0.23

Correlation Coefficient

NeOnc Technologies  Insight Molecular

Modest diversification

The 3 months correlation between NeOnc and Insight is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding NeOnc Technologies Holdings, and Insight Molecular Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insight Molecular and NeOnc Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeOnc Technologies Holdings, are associated (or correlated) with Insight Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insight Molecular has no effect on the direction of NeOnc Technologies i.e., NeOnc Technologies and Insight Molecular go up and down completely randomly.

Pair Corralation between NeOnc Technologies and Insight Molecular

Given the investment horizon of 90 days NeOnc Technologies is expected to generate 1.96 times less return on investment than Insight Molecular. In addition to that, NeOnc Technologies is 1.29 times more volatile than Insight Molecular Diagnostics. It trades about 0.13 of its total potential returns per unit of risk. Insight Molecular Diagnostics is currently generating about 0.33 per unit of volatility. If you would invest  260.00  in Insight Molecular Diagnostics on August 19, 2025 and sell it today you would earn a total of  480.00  from holding Insight Molecular Diagnostics or generate 184.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

NeOnc Technologies Holdings,  vs.  Insight Molecular Diagnostics

NeOnc Technologies

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in NeOnc Technologies Holdings, are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain technical indicators, NeOnc Technologies demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Insight Molecular

Risk-Adjusted Performance

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Insight Molecular Diagnostics are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Insight Molecular showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with NeOnc Technologies and Insight Molecular

The main advantage of trading using opposite NeOnc Technologies and Insight Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeOnc Technologies position performs unexpectedly, Insight Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insight Molecular will offset losses from the drop in Insight Molecular's long position.

The idea behind NeOnc Technologies Holdings, and Insight Molecular Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..